"Subang Jaya Medical Centre (SJMC) is the flagship hospital of Ramsay Sime Darby Health Care, a joint venture between Ramsay Health Care, Australia and Sime Darby, Malaysia. It is a 444-bed multi-disciplinary and tertiary care private hospital located in the bustling subarban township of Subang Jaya, about 30 minute drive to Kuala Lumpur city centre and the Kuala Lumpur International Airport (KLIA) via major highways."

During the past decade, Subang Jaya Medical Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Subang Jaya Medical Centre" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "National Hospital Organization Nagoya Medical Center" with 1 trials sponsored, "National University Hospital, Singapore" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Singapore General Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Subang Jaya Medical Centre" #1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Subang Jaya Medical Centre" are "Acute Lymphoblastic Leukemia" (1 trials), "Acute Lymphoblastic Leukemia (ALL)" (1 trials), "Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)" (1 trials), "Angioimmunoblastic T-cell Lymphoma" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Subang Jaya Medical Centre" in a lesser frequency.

Most popular intervention types in "Subang Jaya Medical Centre" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "6-Mercaptopurine" (2 trials), "Bortezomib" (2 trials), "Cyclophosphamide" (2 trials), "Cytarabine" (2 trials) and "Daunorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Subang Jaya Medical Centre" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Subang Jaya Medical Centre". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Subang Jaya Medical Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Subang Jaya Medical Centre, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".